Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations

Figure 2

BrdU and TUNEL analysis after RNAi treatment. (a) BRAF knockdown using BRAF-C2 siRNA induces a significant (*p < 0.05) decrease in BrdU incorporation in comparison to the siRNA control in the three cell lines. (b) Inhibition of BRAF had no major effect on apoptosis as measured by TUNEL assay in 8505C and C643. In TPC1 cells there was a significant (*p < 0.05) increase in apoptosis when compared with the controls. All values presented are the mean of at least three independent experiments. In both, BrdU and TUNEL analysis, siRNA control did not produce any significant effect in comparison to the blank and transfection controls.

Back to article page